Literature DB >> 12239717

Three novel DNMT3B mutations in Japanese patients with ICF syndrome.

Hisao Shirohzu1, Takeo Kubota, Azumi Kumazawa, Takashi Sado, Takahito Chijiwa, Kouichi Inagaki, Isao Suetake, Shoji Tajima, Keiko Wakui, Yuko Miki, Masatoshi Hayashi, Yoshimitsu Fukushima, Hiroyuki Sasaki.   

Abstract

ICF syndrome is a rare autosomal recessive disorder characterized by immunodeficiency, centromeric instability, and facial anomalies. It is caused by mutations in a de novo DNA methyltransferase gene, DNMT3B. We here report the first three Japanese cases of ICF syndrome from two unrelated families. All patients had typical facial dysmorphism and immunoglobulin A (IgA) deficiency, but none of them had apparent mental retardation. Cytogenetic analysis of peripheral blood lymphocytes showed chromosomal abnormalities, including multiradial configurations and a stretching of the pericentromeric heterochromatin of chromosomes 1 and 16. Hypomethylation of classical satellite 2 DNA was also observed. Mutation analyses of DNMT3B revealed three novel mutations: patient 1 from the first family was a compound heterozygote for a nonsense mutation (Q42Term) and a missense mutation (R832Q); patients 2 and 3 from the second family were both homozygous for a missense mutation (S282P). The R832Q mutation occurred within the conserved methyltransferase domain, and thus may affect the enzyme activity directly. The S282P mutation, on the other hand, occurred close to the PWWP domain, which is presumably involved in protein-protein interaction. This is the first missense mutation mapped to the N-terminal half of the protein, suggesting that the region plays an important role in the regulation of the DNMT3B enzyme. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239717     DOI: 10.1002/ajmg.10658

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  34 in total

1.  Mechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions.

Authors:  Matthew J Betts; Qianhao Lu; YingYing Jiang; Armin Drusko; Oliver Wichmann; Mathias Utz; Ilse A Valtierra-Gutiérrez; Matthias Schlesner; Natalie Jaeger; David T Jones; Stefan Pfister; Peter Lichter; Roland Eils; Reiner Siebert; Peer Bork; Gordana Apic; Anne-Claude Gavin; Robert B Russell
Journal:  Nucleic Acids Res       Date:  2014-11-11       Impact factor: 16.971

2.  The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin.

Authors:  Taiping Chen; Naomi Tsujimoto; En Li
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

3.  The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation.

Authors:  Arunkumar Dhayalan; Arumugam Rajavelu; Philipp Rathert; Raluca Tamas; Renata Z Jurkowska; Sergey Ragozin; Albert Jeltsch
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

4.  Epigenetics in congenital diseases and pervasive developmental disorders.

Authors:  Takeo Kubota
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

5.  Obstructive heart defects associated with candidate genes, maternal obesity, and folic acid supplementation.

Authors:  Xinyu Tang; Mario A Cleves; Todd G Nick; Ming Li; Stewart L MacLeod; Stephen W Erickson; Jingyun Li; Gary M Shaw; Bridget S Mosley; Charlotte A Hobbs
Journal:  Am J Med Genet A       Date:  2015-04-02       Impact factor: 2.802

6.  ICF syndrome in Saudi Arabia: immunological, cytogenetic and molecular analysis.

Authors:  Namik Kaya; Saleh Al-Muhsen; Bandar Al-Saud; Albandary Al-Bakheet; Dilek Colak; Abdulaziz Al-Ghonaium; Hasan Al-Dhekri; Hamoud Al-Mousa; Rand Arnaout; Mohammad Al-Owain; Mohammad Iqbal
Journal:  J Clin Immunol       Date:  2010-12-01       Impact factor: 8.317

7.  Clinical and Immunological Characterization of ICF Syndrome in Japan.

Authors:  Chikako Kamae; Kohsuke Imai; Tamaki Kato; Tsubasa Okano; Kenichi Honma; Noriko Nakagawa; Tzu-Wen Yeh; Emiko Noguchi; Akira Ohara; Tomonari Shigemura; Hiroshi Takahashi; Shunichi Takakura; Masatoshi Hayashi; Aoi Honma; Seiichi Watanabe; Tomoko Shigemori; Osamu Ohara; Hiroyuki Sasaki; Takeo Kubota; Tomohiro Morio; Hirokazu Kanegane; Shigeaki Nonoyama
Journal:  J Clin Immunol       Date:  2018-10-23       Impact factor: 8.317

8.  Identification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cells.

Authors:  Shoumei Bai; Kalpana Ghoshal; Samson T Jacob
Journal:  J Biol Chem       Date:  2006-03-14       Impact factor: 5.157

9.  Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects.

Authors:  Corry M R Weemaes; Maarten J D van Tol; Jun Wang; Monique M van Ostaijen-ten Dam; Marja C J A van Eggermond; Peter E Thijssen; Caner Aytekin; Nicola Brunetti-Pierri; Mirjam van der Burg; E Graham Davies; Alina Ferster; Dieter Furthner; Giorgio Gimelli; Andy Gennery; Barbara Kloeckener-Gruissem; Stephan Meyn; Cynthia Powell; Ismail Reisli; Catharina Schuetz; Ansgar Schulz; Andrea Shugar; Peter J van den Elsen; Silvère M van der Maarel
Journal:  Eur J Hum Genet       Date:  2013-03-13       Impact factor: 4.246

10.  DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1.

Authors:  Jinah Park; Tae-You Kim; Yeonjoo Jung; Sang-Hyun Song; Sung-Hak Kim; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang
Journal:  J Mol Med (Berl)       Date:  2008-09-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.